Evaluating the burden of amblyopia treatment from the parent and child's perspective

Joost Felius, Danielle L. Chandler, Jonathan M. Holmes, Raymond H. Chu, Stephen R. Cole, Michael Hill, Kristine Huang, Marjean Taylor Kulp, Elizabeth L. Lazar, Noelle S. Matta, Michele Melia, David K. Wallace

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Purpose: To evaluate the psychometric properties of the original Parent and new Child Amblyopia Treatment Index (ATI), questionnaires that assess the burden of amblyopia treatment in children and families, and to compare scores between children treated with atropine or patching. Methods: Parent ATI and Child ATI were administered to 233 children 7 to <13 years old and their parents as part of a randomized trial comparing patching and atropine for amblyopia treatment. For each ATI version, construct validity was assessed using factor analysis; internal consistency reliability was assessed using Cronbach's alpha. Data from the Parent ATI and Child ATI were correlated and scores for each version were compared between treatment groups. Results: We analyzed the 3 subscales found in prior Parent ATI studies in younger children and confirmed subscales for adverse effects and treatment compliance, but not for social stigma, in both parent and child versions. Overall and subscale scores on the Parent ATI and Child ATI were moderately to well correlated except for the social stigma subscale. For both the Parent ATI and the Child ATI, children treated with atropine had better scores than those treated with patching, both overall and on treatment compliance and social stigma subscales (all p values ≤ 0.01). Conclusions: When used for children 7 to <13 years old, the Parent ATI and Child ATI have similar factor structures to each other and to the Parent ATI for children 3 to <7 years old. Atropine treatment was found to have less negative impact than patching.

Original languageEnglish (US)
Pages (from-to)389-395
Number of pages7
JournalJournal of AAPOS
Volume14
Issue number5
DOIs
StatePublished - Oct 1 2010
Externally publishedYes

Fingerprint

Amblyopia
Therapeutics
Social Stigma
Atropine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Ophthalmology

Cite this

Evaluating the burden of amblyopia treatment from the parent and child's perspective. / Felius, Joost; Chandler, Danielle L.; Holmes, Jonathan M.; Chu, Raymond H.; Cole, Stephen R.; Hill, Michael; Huang, Kristine; Kulp, Marjean Taylor; Lazar, Elizabeth L.; Matta, Noelle S.; Melia, Michele; Wallace, David K.

In: Journal of AAPOS, Vol. 14, No. 5, 01.10.2010, p. 389-395.

Research output: Contribution to journalArticle

Felius, J, Chandler, DL, Holmes, JM, Chu, RH, Cole, SR, Hill, M, Huang, K, Kulp, MT, Lazar, EL, Matta, NS, Melia, M & Wallace, DK 2010, 'Evaluating the burden of amblyopia treatment from the parent and child's perspective', Journal of AAPOS, vol. 14, no. 5, pp. 389-395. https://doi.org/10.1016/j.jaapos.2010.07.009
Felius, Joost ; Chandler, Danielle L. ; Holmes, Jonathan M. ; Chu, Raymond H. ; Cole, Stephen R. ; Hill, Michael ; Huang, Kristine ; Kulp, Marjean Taylor ; Lazar, Elizabeth L. ; Matta, Noelle S. ; Melia, Michele ; Wallace, David K. / Evaluating the burden of amblyopia treatment from the parent and child's perspective. In: Journal of AAPOS. 2010 ; Vol. 14, No. 5. pp. 389-395.
@article{a0250ac0cada41da8a24d8b66e3eab0a,
title = "Evaluating the burden of amblyopia treatment from the parent and child's perspective",
abstract = "Purpose: To evaluate the psychometric properties of the original Parent and new Child Amblyopia Treatment Index (ATI), questionnaires that assess the burden of amblyopia treatment in children and families, and to compare scores between children treated with atropine or patching. Methods: Parent ATI and Child ATI were administered to 233 children 7 to <13 years old and their parents as part of a randomized trial comparing patching and atropine for amblyopia treatment. For each ATI version, construct validity was assessed using factor analysis; internal consistency reliability was assessed using Cronbach's alpha. Data from the Parent ATI and Child ATI were correlated and scores for each version were compared between treatment groups. Results: We analyzed the 3 subscales found in prior Parent ATI studies in younger children and confirmed subscales for adverse effects and treatment compliance, but not for social stigma, in both parent and child versions. Overall and subscale scores on the Parent ATI and Child ATI were moderately to well correlated except for the social stigma subscale. For both the Parent ATI and the Child ATI, children treated with atropine had better scores than those treated with patching, both overall and on treatment compliance and social stigma subscales (all p values ≤ 0.01). Conclusions: When used for children 7 to <13 years old, the Parent ATI and Child ATI have similar factor structures to each other and to the Parent ATI for children 3 to <7 years old. Atropine treatment was found to have less negative impact than patching.",
author = "Joost Felius and Chandler, {Danielle L.} and Holmes, {Jonathan M.} and Chu, {Raymond H.} and Cole, {Stephen R.} and Michael Hill and Kristine Huang and Kulp, {Marjean Taylor} and Lazar, {Elizabeth L.} and Matta, {Noelle S.} and Michele Melia and Wallace, {David K.}",
year = "2010",
month = "10",
day = "1",
doi = "10.1016/j.jaapos.2010.07.009",
language = "English (US)",
volume = "14",
pages = "389--395",
journal = "Journal of AAPOS",
issn = "1091-8531",
publisher = "Mosby Inc.",
number = "5",

}

TY - JOUR

T1 - Evaluating the burden of amblyopia treatment from the parent and child's perspective

AU - Felius, Joost

AU - Chandler, Danielle L.

AU - Holmes, Jonathan M.

AU - Chu, Raymond H.

AU - Cole, Stephen R.

AU - Hill, Michael

AU - Huang, Kristine

AU - Kulp, Marjean Taylor

AU - Lazar, Elizabeth L.

AU - Matta, Noelle S.

AU - Melia, Michele

AU - Wallace, David K.

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Purpose: To evaluate the psychometric properties of the original Parent and new Child Amblyopia Treatment Index (ATI), questionnaires that assess the burden of amblyopia treatment in children and families, and to compare scores between children treated with atropine or patching. Methods: Parent ATI and Child ATI were administered to 233 children 7 to <13 years old and their parents as part of a randomized trial comparing patching and atropine for amblyopia treatment. For each ATI version, construct validity was assessed using factor analysis; internal consistency reliability was assessed using Cronbach's alpha. Data from the Parent ATI and Child ATI were correlated and scores for each version were compared between treatment groups. Results: We analyzed the 3 subscales found in prior Parent ATI studies in younger children and confirmed subscales for adverse effects and treatment compliance, but not for social stigma, in both parent and child versions. Overall and subscale scores on the Parent ATI and Child ATI were moderately to well correlated except for the social stigma subscale. For both the Parent ATI and the Child ATI, children treated with atropine had better scores than those treated with patching, both overall and on treatment compliance and social stigma subscales (all p values ≤ 0.01). Conclusions: When used for children 7 to <13 years old, the Parent ATI and Child ATI have similar factor structures to each other and to the Parent ATI for children 3 to <7 years old. Atropine treatment was found to have less negative impact than patching.

AB - Purpose: To evaluate the psychometric properties of the original Parent and new Child Amblyopia Treatment Index (ATI), questionnaires that assess the burden of amblyopia treatment in children and families, and to compare scores between children treated with atropine or patching. Methods: Parent ATI and Child ATI were administered to 233 children 7 to <13 years old and their parents as part of a randomized trial comparing patching and atropine for amblyopia treatment. For each ATI version, construct validity was assessed using factor analysis; internal consistency reliability was assessed using Cronbach's alpha. Data from the Parent ATI and Child ATI were correlated and scores for each version were compared between treatment groups. Results: We analyzed the 3 subscales found in prior Parent ATI studies in younger children and confirmed subscales for adverse effects and treatment compliance, but not for social stigma, in both parent and child versions. Overall and subscale scores on the Parent ATI and Child ATI were moderately to well correlated except for the social stigma subscale. For both the Parent ATI and the Child ATI, children treated with atropine had better scores than those treated with patching, both overall and on treatment compliance and social stigma subscales (all p values ≤ 0.01). Conclusions: When used for children 7 to <13 years old, the Parent ATI and Child ATI have similar factor structures to each other and to the Parent ATI for children 3 to <7 years old. Atropine treatment was found to have less negative impact than patching.

UR - http://www.scopus.com/inward/record.url?scp=78049371836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049371836&partnerID=8YFLogxK

U2 - 10.1016/j.jaapos.2010.07.009

DO - 10.1016/j.jaapos.2010.07.009

M3 - Article

VL - 14

SP - 389

EP - 395

JO - Journal of AAPOS

JF - Journal of AAPOS

SN - 1091-8531

IS - 5

ER -